All Cosmos Bio-Tech Holding Corporation

Taiwan Stock Exchange 4148.TW

All Cosmos Bio-Tech Holding Corporation Price to Earnings Ratio (P/E) on January 14, 2025: 20.78

All Cosmos Bio-Tech Holding Corporation Price to Earnings Ratio (P/E) is 20.78 on January 14, 2025, a -2.18% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.

All Cosmos Bio-Tech Holding Corporation 52-week high Price to Earnings Ratio (P/E) is 24.98 on March 25, 2024, which is 20.17% above the current Price to Earnings Ratio (P/E).
All Cosmos Bio-Tech Holding Corporation 52-week low Price to Earnings Ratio (P/E) is 19.65 on December 20, 2024, which is -5.47% below the current Price to Earnings Ratio (P/E).
All Cosmos Bio-Tech Holding Corporation average Price to Earnings Ratio (P/E) for the last 52 weeks is 22.19.

Key data

Date	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield

Taiwan Stock Exchange: 4148.TW

All Cosmos Bio-Tech Holding Corporation

CEO	Dr. Shih Hao Peng Ph.D.
IPO Date	June 9, 2017
Location	Cayman Islands
Headquarters	190 Elgin Avenue
Employees	368
Sector	Health Care
Industries Biotechnology Fertilizers

Description

All Cosmos Bio-Tech Holding Corporation, through its subsidiaries, manufactures and sells bio-organic and bio-chemical compound fertilizers in Malaysia. It also engages in the research and development of microorganisms for waste disposal of oil-palm; and wholesale of probiotics. In addition, the company is involved in the research and forest plantation activities. It also exports its products to Taiwan, Indonesia, Vietnam, and China. All Cosmos Bio-Tech Holding Corporation was founded in 1999 and is headquartered in George Town, the Cayman Islands.

Key trends

Past 5 years